Aragen Bioscience is a world leader in accelerating preclinical respiratory disease and fibrosis research. With over 500 fibrosis focused studies under our belt, our strengths lie in translational in vivo modelling of a variety of fibrotic diseases including pulmonary fibrosis. We have combined our strength in IPF with our strength in infectious diseases to help understand potential links between IPF and infectious respiratory diseases. We have perfected the measurement of parameters such as flexiVent™; whole-body plethysmography; and hypoxia related parameters in our animal models and have supported these measurements with a broad suite of biomarkers of respiratory pathophysiology, disease progression, and treatment. We are based in the San Francisco Bay area.